Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
Launched by LUNGEVITY FOUNDATION · Apr 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Project PEER study, organized by the LUNGevity Foundation, aims to understand the experiences of people living with lung cancer and their caregivers. By participating in this online study, you will help researchers learn how different treatments affect the everyday lives of lung cancer patients. If you join, you will receive a survey each month for a year, which you can complete at your convenience using a smartphone, tablet, or computer. For your time, you will receive an e-gift card.
To be eligible, you should be an adult with a lung cancer diagnosis or a caregiver of someone who has lung cancer (as long as the patient is alive). You need to be able to read and answer questions in English and have access to the internet. Unfortunately, those under 18 or healthcare providers who treat lung cancer patients cannot participate. This study is a great opportunity to share your insights and experiences, helping to improve the understanding of lung cancer care for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults with self-reported lung cancer diagnosis or caregiver of someone with a self-reported lung cancer diagnosis (patient has to be alive)
- • Ability to read and answer questions in English
- • Access and ability to use a computer or other internet-connected device
- Exclusion Criteria:
- • Younger than 18
- • Healthcare providers and healthcare professionals who provide care to lung cancer patients except for those who are themselves a patient or a caregiver to a loved one.
- • Not able to provide informed consent
About Lungevity Foundation
LUNGevity Foundation is a leading nonprofit organization dedicated to advancing research and improving patient outcomes in lung cancer. Through innovative clinical trial sponsorship and funding initiatives, LUNGevity aims to accelerate the development of effective therapies and enhance the quality of life for lung cancer patients. The foundation collaborates with researchers, healthcare professionals, and advocacy groups to promote awareness, support patient education, and drive meaningful progress in lung cancer treatment. Committed to fostering a community of hope and support, LUNGevity is at the forefront of transforming lung cancer care through strategic partnerships and groundbreaking research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
Trial Officials
Upal Basu Roy, PhD, MPH
Principal Investigator
LUNGevity Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported